Who Are We?
We are a Pittsburgh, PA-based biotechnology company developing next generation therapies and diagnostics to improve outcomes for patients with hematological cancers.
The GEAR Management Team
GEAR Therapeutics was formed in 2024 and is a wholly owned subsidiary of Coeptis Therapeutics Holdings, Inc (“Coeptis”). GEAR enjoys the benefits of utilizing Coeptis’ management, scientific advisors, personnel, consultants, and infrastructure.
Scientists Behind GEAR
Evren Alici M.D., Ph.D.
Head of the Gene and Cell Therapy Group, Division of Hematology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm
Hans-Gustaf Ljunggren, M.D., Ph.D.
Former Dean of Research, Karolinska Institutet and founder of the Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm
Arnika K. Wagner, Ph.D.
Assistant Professor, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm
Our Goals
- Develop novel therapeutics
- Improve patient outcomes
- Disrupt industry norms
- Revolutionize cancer therapy